US equities
|
NVDA
$239.65
▲+2.44%
SPCX
$169.89
▲+6.88%
MU
$1,062.18
▼-1.18%
TSLA
$379.96
▲+2.53%
SNDK
$1,701.31
▼-1.09%
MSFT
$528.08
▲+2.04%
INTC
$116.15
▼-2.66%
META
$742.78
▲+2.02%
NVDA
$239.65
▲+2.44%
SPCX
$169.89
▲+6.88%
MU
$1,062.18
▼-1.18%
TSLA
$379.96
▲+2.53%
SNDK
$1,701.31
▼-1.09%
MSFT
$528.08
▲+2.04%
INTC
$116.15
▼-2.66%
META
$742.78
▲+2.02%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Halberd Corp
(OP:
HALB
)
0.0015
-0.0005 (-25.00%)
Delayed Quote
Updated: 3:24 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Halberd Corp
< Previous
1
2
3
4
5
Next >
Halberd Corporation CEO Letter
July 06, 2021
Q2-21 Accomplishments and Q3 Plans JACKSON CENTER, PA / ACCESSWIRE / July 6, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC PINK: HALB) As we began the second quarter, the...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process
June 30, 2021
Method Does Not Require Antibody Conjugated Metallic Nanoparticles JACKSON CENTER, PA / ACCESSWIRE / June 30, 2021 / Halberd Corporation (OTC PINK:HALB) announces a possible breakthrough method for the...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation's Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage Process
June 21, 2021
JACKSON CENTER, PA / ACCESSWIRE / June 21, 2021 / Halberd Corporation's (OTC PINK:HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens
June 16, 2021
Enables Extracorporeal Eradication of Pathogens from Cerebral Spinal Fluid Via Radio Frequency and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / June 16, 2021 / Halberd Corporation (OTC...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease
June 09, 2021
JACKSON CENTER, PA / ACCESSWIRE / June 9, 2021 / Halberd Corporation (OTC PINK:HALB) commences experimentations to eradicate three of the principal components of Alzheimer's Disease. By eliminating...
From
Halberd Corporation
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Halberd Corporation Creates Two New and Stronger SARS-CoV-2 Neutralizing Antibodies
June 07, 2021
Demonstrates Greater Binding Affinity Than Previous Antibodies JACKSON CENTER, PA / ACCESSWIRE / June 7, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful creation of two new...
From
Halberd Corporation
Via
AccessWire
Topics
Animal Testing
Intellectual Property
Regulatory Compliance
Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects
June 01, 2021
JACKSON CENTER, PA / ACCESSWIRE / June 1, 2021 / Halberd Corporation (OTC PINK:HALB) announced the filing of a U. S. joint provisional patent application titled, "Antibody Conjugated Nanoparticle Assay...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Successfully Conjugates Metallic Particles and E. Coli Antibody
May 25, 2021
Breakthrough Achievement Enables Extracorporeal Eradication of Pathogens Via Radio Frequency Waves and/or Laser Emissive Energy JACKSON CENTER, PA / ACCESSWIRE / May 25, 2021 / Halberd Corporation (OTC...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19
May 19, 2021
JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Reports Successful Conjugation of Metallic Particles & SARS-CoV-2 Proprietary Monoclonal Antibody
May 17, 2021
JACKSON CENTER, PA / ACCESSWIRE / May 17, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful conjugation of gold-coated iron nanoparticles with Halberd's patent-pending monoclonal...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Begins Testing of Patented Process for Laser Eradication of Disease
May 13, 2021
JACKSON CENTER, PA / ACCESSWIRE / May 13, 2021 / Halberd Corporation (OTC PINK:HALB) announces the commencement of its patented extra-corporeal process experimentation using lasers to eradicate...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications
May 10, 2021
JACKSON CENTER, PA / ACCESSWIRE / May 10, 2021 / Halberd Corporation (OTC PINK:HALB) was recently discussed in Penny Stocks News and Wall Street Trader publications as a BREAKOUT stock to watch with a...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease
May 04, 2021
JACKSON CENTER, PA / ACCESSWIRE / May 4, 2021 / Halberd Corporation (OTC PINK:HALB) announces the appointment of Dr. Mitchell S. Felder, previously a consultant to Halberd Corporation, to the position...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser
April 26, 2021
JACKSON CENTER, PA / ACCESSWIRE / April 26, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, "Treating...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations
April 21, 2021
JACKSON CENTER, PA / ACCESSWIRE / April 21, 2021 / Halberd Corporation's (OTC PINK:HALB) two patent-pending monoclonal antibodies have demonstrated strong affinity and neutralizing capabilities against...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Moves Radio Frequency (RF) Disease Elimination Effort Forward with the Addition of Youngstown State University (YSU) and Dr. William G. Sturrus
April 19, 2021
Brings Critical Radio Frequency Wave Expertise to Company's Effort JACKSON CENTER, PA / ACCESSWIRE / April 19, 2021 / Halberd Corporation (OTC PINK:HALB) is pleased to announce Youngstown State...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment
April 12, 2021
JACKSON CENTER, PA / ACCESSWIRE / April 12, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, "Covid-19...
From
Halberd Corporation
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
< Previous
1
2
3
4
5
Next >
